Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by Javid Fazili and Mohammad Madhoun.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.291
         
        
        
     
 
    
        
        - 
            Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014 May 14; 20(18):5442-60.
            
            
                Score: 0.113
            
         
        
        - 
            Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73.
            
            
                Score: 0.084
            
         
        
        - 
            Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. Eur J Gastroenterol Hepatol. 2018 Mar; 30(3):296-301.
            
            
                Score: 0.037
            
         
        
        - 
            Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
            
            
                Score: 0.031
            
         
        
        - 
            A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients. J Viral Hepat. 2013 Sep; 20(9):622-7.
            
            
                Score: 0.026